AUSTIN, Texas, Aug. 9 /PRNewswire-FirstCall/ -- Introgen Therapeutics, Inc. (Nasdaq: INGN) announced today that the Company and the FDA have reached agreement to ...
Houston and Austin, TX, October 25, 2001- Introgen Therapeutics, Inc. (NASDAQ: INGN) announced today that results of preclinical studies in melanoma have been published in the October 2001 issue of ...
AUSTIN, Texas--(BUSINESS WIRE)--Dec. 3, 2008--As part of its ongoing restructuring, Introgen Therapeutics, Inc. (NASDAQ:INGN), today announced that the company has elected to file Chapter 11 petitions ...
Introgen Therapeutics, Inc. has announced that a patent has been awarded by the U.S. Patent and Trademark Office which covers, for example, administration of chemotherapeutic drugs, radiation ...
AUSTIN, Texas, Dec. 13 /PRNewswire-FirstCall/ -- Introgen Therapeutics, Inc. (Nasdaq: INGN) announced today that it has been granted a broad patent by the European ...
Chief Executive Officer, Other Senior Executive Officers, Resign in Connection with Cost Cutting Move AUSTIN, Texas, Nov 26, 2008 (BUSINESS WIRE) -- Introgen Therapeutics, Inc. (NASDAQ:INGN), today ...
With a lack of products, Introgen's burn rate is a key factor for investors to figure out its chance of survival. You'd think that after more than a decade of research, a company without any products ...
A reduction in operating expenses helped Introgen Therapeutics Inc. lower its second quarter loss, but the biopharmaceutical company is still facing concerns over the effectiveness of its flagship ...
AUSTIN, Texas--(BUSINESS WIRE)--Introgen Therapeutics, Inc. (NASDAQ:INGN) announced today that it will host a conference call with management and invited clinical experts on Thursday, July 10, 2008 at ...
Introgen Therapeutics Inc., an Austin-based drug development company, has filed to issue up to $150 million worth of stock with the Securities and Exchange Commission. Introgen (NASDAQ: INGN) says it ...
A cancer drug gets fast-tracked and sends the stock soaring. A small Texas biotechnology company, Introgen (NASDAQ:INGN), hit one out of the park this week, rising over 22% Wednesday on news that one ...
If you look on the fifth page of Gov. Rick Perry’s personal financial disclosure form on file at the Texas Ethics Commission, the first investment listed is for his son Griffin’s trust fund. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results